EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vasopressin Improves Cerebral Perfusion Pressure but Not Cerebral Blood Flow or Tissue Oxygenation in Patients with Subarachnoid Hemorrhage and Norepinephrine-Refractory Hypotension: A Preliminary Evaluation

Sylvia Bele iD, Elisabeth Bruendl iD, Nils Ole Schmidt iD, Martin Proescholdt, Martin Kieninger

Journal of Clinical Medicine · 01.12.2025 · 14 (23) · 8517

DOI: 10.3390/jcm14238517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 01.12.2025. Verfasst von Sylvia Bele und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Regensburg University Medical Center, 93052 Regensburg, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Maintaining an adequate mean arterial pressure (MAP) and cerebral perfusion pressure to ensure proper perfusion and oxygen delivery to all major organs is crucial—especially for neurosurgical patients after subarachnoid hemorrhage or traumatic brain injury—for preventing secondary brain damage or delayed cerebral ischemia. Currently, most neurosurgical intensive care units rely on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) values to guide therapy. Fluid resuscitation and norepinephrine are standard treatments for achieving a CPP between 60 and 70 mmHg; however, patients sometimes experience norepinephrine-refractory hypotension. In such cases, vasopressin is often the preferred medication; it is widely utilized and has gained interest in treating septic shock or refractory hypotension following cardiac surgery or hypovolemic shock. Recent studies have also shown the significant impact of vasopressin on resuscitation after traumatic brain injury (TBI) and its effect on CPP during ICU care. Nevertheless, little is known about how vasopressin affects cerebral perfusion and oxygenation, especially in patients with subarachnoid hemorrhage.

Methods

This preliminary retrospective single-arm study examined how vasopressin affects PbtO2 and cerebral blood flow using the non-invasive QuantixND® device. After administering vasopressin for treating catecholamine-refractory hypotension, MAP, CPP, ICP, PbtO2, and cerebral blood flow were measured over a 20-min period.

Results

In this small cohort, vasopressin sufficiently improved MAP and CPP over a 20 min period following AVP bolus administration with a slight decline at later time points. The ICP decreased throughout this period, indicating some level of autoregulation. In contrast, cerebral blood flow did not improve despite the rise in CPP, and PbtO2 levels remained below 20 mmHg.

Conclusions

We conclude that vasopressin could be a viable option for maintaining MAP and CPP, but caution should be exercised in patients with already impaired cerebral perfusion. Furthermore, relying solely on CPP as the therapeutic guide in subarachnoid hemorrhage patients appears to be at least questionable.

Schlagwörter

Stichwörter der Autor:innen

brain tissue oxygenationcerebral blood flowcerebral perfusion pressurenorepinephrine-refractory hypotensionsubarachnoid hemorrhagevasopressin

Autor:innen und Institutionen

  • Department of Neurosurgery, Regensburg University Medical Center, 93052 Regensburg, Germany.
  • Department of Anesthesiology, Regensburg University Medical Center, 93052 Regensburg, Germany.

ORCID-Profile: Sylvia Bele, Elisabeth Bruendl, Nils Ole Schmidt

Zitieren

APA

Bele, S., Bruendl, E., Schmidt, N. O., Proescholdt, M., & Kieninger, M. (2025). Vasopressin Improves Cerebral Perfusion Pressure but Not Cerebral Blood Flow or Tissue Oxygenation in Patients with Subarachnoid Hemorrhage and Norepinephrine-Refractory Hypotension: A Preliminary Evaluation. Journal of Clinical Medicine, 14(23), 8517. https://doi.org/10.3390/jcm14238517

Vancouver

Bele S, Bruendl E, Schmidt NO, Proescholdt M, Kieninger M. Vasopressin Improves Cerebral Perfusion Pressure but Not Cerebral Blood Flow or Tissue Oxygenation in Patients with Subarachnoid Hemorrhage and Norepinephrine-Refractory Hypotension: A Preliminary Evaluation. Journal of Clinical Medicine. 2025;14(23):8517. doi:10.3390/jcm14238517

BibTeX
@article{Bele2025,
  author = {Bele, Sylvia and Bruendl, Elisabeth and Schmidt, Nils Ole and Proescholdt, Martin and Kieninger, Martin},
  title = {Vasopressin Improves Cerebral Perfusion Pressure but Not Cerebral Blood Flow or Tissue Oxygenation in Patients with Subarachnoid Hemorrhage and Norepinephrine-Refractory Hypotension: A Preliminary Evaluation},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {23},
  pages = {8517},
  doi = {10.3390/jcm14238517}
}
Kostenlos starten →